• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

A New Algorithm to Treat Patients with Peripheral Vascular Disease

  • Wed, 1/18/12 - 10:28am
  • 728 reads
  • 0 comments

Peripheral vascular disease (PVD) consists of vascular disease outside of the coronary bed. Atherosclerosis is the dominant cause of PVD. Patients with PVD carry high mortality and morbidity due to increased incidence of stroke and myocardial infarction in these patients. Management of PVD should include risk factor reduction for atherosclerosis. Patients who continue to be symptomatic or continue to progress in disease severity despite optimal medical therapy may need revascularization. We describe a new proposal of algorithm (mnemonics) ABCDE aiming to prevent PVD.

ABCDE of Peripheral Vascular Disease Prevention

A: Anti-platelets

  1. Aspirin
  • Peripheral arterial disease
  • Coronary artery disease
  • Men >60 years 
  • Women >50 years
  • Transient ischemia attack 
  • Cerebrovascular accident
  1. Clopidogrel
  • Myocardial infarction
  • Transient ischemia attack
  • Cerebrovascular accident 
  • Critical limb ischemia
  1.  Cilostozol
  • Claudication

B1: Beta Blockers

  1. Congestive heart failure
  2. Myocardial infarction

B2: Blood Pressure

  1. All hypertensive patients are preferably treated with angiotensin converting enzyme (ACE) inhibitors first.
  2. Encourage diuretic to be first line of management.

C1: Cholesterol Management

  1. Myocardial infarction
  2. Transient ischemia attack
  3. Cerebrovascular accident
  4. Peripheral arterial disease with LDL >100
  5. Transient ischemia attack

C2: Cessation of Tobacco

  1. Active cigarette smoking
  • Counseling by trained tobacco cessation specialists
  1. Chewing tobacco/Pipe smoking
  • Refer to primary care physician for pharmacological intervention

D2: Diet counseling: All diet counseling by dietician, physician, and physician extenders. 

  1. Hypertension
  • Low salt diet, high fiber
  1. Diabetes mellitus
  • American diabetic association diet
  1. Hypercholesterolemia
  • Low cholesterol, high fiber diet
  1. Obesity/Overweight/Based on BMI
  • Low cholesterol, low fat diet
  • Referral to weight loss program

E1: Exercise: Specific counseling by physicians, physician extenders, and exercise physiologists.

  1. All PAD patients
  • Exercise for a minimum of 30 minutes 3 to 5 times per week
  1. Patients with claudication
  • Supervised exercise program
  • Home claudication walk log book
  • Pedometer or walking meter
image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

When Will U.S. See New Lower Limb Devices?

Lawrence A. Garcia MD

Bridge To Nowhere

John E. Lassetter MD FACC FSCAI

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease
    Tue, 02/21/12 - 2:25pm
  • Promising new compound for treating stroke
    Tue, 02/21/12 - 9:13am
  • HHS Announces Intent to Delay ICD-10 Compliance Date
    Fri, 02/17/12 - 2:27pm
  • Aptus Endosystems Initiates the ANCHOR Post-Market Registry
    Tue, 02/14/12 - 2:16pm
more »

Clinical Events Calendar

  • Chronic Total Occlusion Summit
    Thu, 02/23/2012 - Sat, 02/25/2012
    New York, NY, United States
  • NCVH Latin America
    Wed, 02/29/2012 - Fri, 03/02/2012
    San Jose, Costa Rica
  • Interventional Cardiology 2012: 27th Annual International Symposium
    Sun, 03/04/2012 - Fri, 03/09/2012
    Snowmass Village, CO, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications